TechSci Healthcare Industry Report

Growing prevalence of chronic diseases  to drive the growth of United States digital therapeutics market According to TechSci Research report,  “ United States  Digital Therapeutics Market  By Product (Software v/s Device), By Sales Channel (B2B v/s B2C), By Application (Preventive Applications v/s Treatment Applications), By Region, Forecast & Opportunities, 2025 ” , the United States digital therapeutics market is expected to grow at a robust rate during the forecast period on account of the increasing technological advancements in mobile healthcare. Additionally, associated benefits such as ability to induce behavioral changes, ease of use, patient convenience, improved patient compliance, among others with digital therapeutics are further expected to propel the market over the next few years. Moreover, digital therapeutics not only address unmet patient needs but also support various stages of patient healthcare journey. They can collect, synthesize and analy...

  Technological advancements in artificial organ industry and growing geriatric population to drive United States artificial organs market According to TechSci Research report,  “ United States Artificial Organs Market  By Organ Type (Artificial Heart (Prosthetic Heart Valves, Ventricular Assist Devices, Cardiac Pacemakers), Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Others), By Technology (Electronic Bionics, Mechanical), By Type of Fixation (Wearable, Implantable), By Material Type (Silicon, Plastic, Steel), By Region, Forecast & Opportunities, 2025” , the United States artificial organs market is expected to witness substantial growth rate during the forecast period owing to the increasing technological and medical advancements in artificial organ manufacturing industry in the country. The country has world’s most advanced healthcare facilities, which is serving as one of the major factors for the growth of this market. Moreover, g...

  Increasing rate of drug development and rising cases of adverse drug reactions to drive United States pharmacovigilance market According to TechSci Research report,  “ United States  Pharmacovigilance Market  By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End-User (Hospitals, Research Organizations, Industries), By Region, Forecast & Opportunities, 2025 ” , the market is expected to undergo robust growth during the forecast period owing to the increasing number of new drug developments, which are creating the need for pharmacovigilance. The changing lifestyle patterns among the population has led to lack of proper diets and prevalence of various chronic diseases including cancer and diabetes. This has escalated the consumption of pharmaceutical...

  According to TechSci Research report,  “United States Biofuel Enzyme Market By Type (Cellulase, Amylase, Xylanase, Lipase, Other), By Source (Microorganism, Plants, Animal), By Reaction Type (Hydrolase, Oxidoreductase, Transferase, Lyase, Others), By Application (Biodiesel, Corn-Based Ethanol, Lignocellulosic Ethanol), By End User Industry (Food and Beverages, Household Care, Bioenergy, Pharmaceutical and Biotechnology, Feed, Others), By Region, Forecast & Opportunities, 2025” , the United States biofuel enzyme market is expected to grow at an impressive rate during the forecast period on account of the growing environmental awareness pertaining to greenhouse gas emissions and need to attain sustainability. Besides, increasing demand from various end user industries such as power, chemical, agriculture, transportation, among others, is further expected to fuel the market growth through 2025. Additionally, rising oil prices have increased the use of biofuels for transport...

  Government's focus on R&D activities in healthcare and increasing approvals for manufacture of generic drugs to drive United States soft tissue sarcoma market According to TechSci Research report,  “ United States  Soft Tissue Sarcoma Market  By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type (Local Sarcoma, Regional Sarcoma, Metastatic Sarcoma), By End User (Hospitals, Oncology Center, Long Term Care Center), By Region, Forecast & Opportunities, 2025 ” , the market is expected to witness a robust CAGR during the forecast period as the government is focusing on investing in research and development activities to find the better treatments for different types of cancer, including soft tissue sarcoma. The rising awareness among people about such diseases and increasing per capita disposable income is also making United States a favorable market for companies manufacturing drugs for soft tissue sarcoma. Ad...

  Innovations in mice models ang growing investments in research is expected to drive the growth of US humanized mice model market According to TechSci Research report,  “ UnitedStates Humanized Mice Model Market  By Service (Breeding, Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End-use (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025 ” , the United States humanized mice model market is expected to grow at a substantial CAGR during the forecast period on account of continuous research and development activities in pharmaceutical companies. In addition to this, rising demand for human...